City
Epaper

Israel cancels mandatory Covid-19 tests for inbound travellers

By IANS | Updated: May 17, 2022 08:05 IST

Jerusalem, May 17 Foreign nationals flying to Israel will no longer be required to take a coronavirus test ...

Open in App

Jerusalem, May 17 Foreign nationals flying to Israel will no longer be required to take a coronavirus test before boarding, the Israeli Health Ministry said.

Earlier this May, the Ministry on Monday allowed foreigners to choose between PCR and antigen tests before boarding, instead of mandatory PCR only. The latest decision, however, cancels any testing requirement.

The easing will take effect on Saturday, Xinhua news agency reported.

All passengers flying to Israel will still be required to fill out a health declaration up to 48 hours before boarding, the Ministry added.

Another obligation that will be abolished is the coronavirus test that has to be taken before boarding a cruise ship departing from Israel, it said.

In early January, Israel allowed the entry of Covid-19 vaccinated and recovered passengers, and then in early March, of all passengers, including the unvaccinated.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Ministry of HealthisraeljerusalemXinhuaIsrAl quds
Open in App

Related Stories

InternationalUS Drops Bunker-Buster Bombs on Iranian Ammunition Depot in Isfahan; Trump Shares Video

NationalUS-Israel-Iran War: Ships Carrying 94,000 Metric Tonnes of LPG Safely Cross Strait of Hormuz, Head Towards India

NationalIndia Plays Crucial Role in Ending War, Says Israel; Sets 4 Conditions for Iran

InternationalIsraeli Air Force Claims Strike in Beirut Killed Hezbollah Operative

InternationalIran’s New Supreme Leader Mojtaba Khamenei in Coma, Loses Leg After Airstrike: Reports

Health Realted Stories

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns